Investigating Epilepsy: Screening and Evaluation

Summary

Participation Requirements

Description

Objectives: The primary objective is to maintain a cohort of patients referred to the NIH with a known or suspected diagnosis of epilepsy for eligibility to participate in ongoing protocols. The secondary objectives are to: follow the natural history of subjects with epilepsy and epilepsy-related di...

Objectives: The primary objective is to maintain a cohort of patients referred to the NIH with a known or suspected diagnosis of epilepsy for eligibility to participate in ongoing protocols. The secondary objectives are to: follow the natural history of subjects with epilepsy and epilepsy-related disorders, and to use data obtained through clinical care for descriptive and/or correlative research. Study Population: Adults and children age 8 years and older referred with a clinical diagnosis of epilepsy Design: Participants In this protocol will be evaluated by study investigators with standard diagnostic clinical studies as clinically indicated to fully characterize their uncontrolled or suspected seizures and related clinical features. There are no study procedures other than data collection for this protocol after screening. Patients will be followed clinically, as needed, to follow the natural history of epilepsy. Follow up will be performed to allow for evaluation of the natural history of drug-resistant epilepsy and its co-morbidities. Outcome Measures: Patients will be screened for eligibility for epilepsy-related research protocols and clinically characterized, including clinical features, imaging, and electrophysiological and neuropsychological characteristics. In addition, standard of care evaluation and treatment will be carried out under this protocol.

Tracking Information